Hypoalbuminemia and hypercalcemia are independently associated with poor treatment outcomes of anti-PD-1 immune checkpoint inhibitors in patients with recurrent or metastatic head and neck squamous cell carcinoma. - Chiu, Tai-Jan; Huang, Tai-Lin; Chien, Chih-Yen; Huang, Wan-Ting; Li, Shau-Hsuan (World Journal of Surgical Oncology, 2024)